A viral mechanism for inhibition of P300 and PCAF acetyltransferase activity

Cell

Volumn 96, Issue 3, 1999, Pages 393-403

  Chakravarti, Debabrata ^a,b   Ogryzko, Vasily ^c   Kao, Hung Ying ^a   Nash, Alyssa ^a,d   Chen, Hongwu ^a   Nakatani, Yoshihiro ^c   Evans, Ronald M ^a,d  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE; ONCOPROTEIN; PROTEIN P53;

ACETYLATION; ADENOVIRUS; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; ENZYME INHIBITION; ENZYME REPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

EID: 0033524942     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80552-8     Document Type: Article

References (44)

1. Arany, Z., Newsome, D., Oldread, E., Livingston, D.M., and Eckner, R. (1995). A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374, 81-84.
2. Barlev, N.A., Poltoratsky, V., Owen-Hughes, T., Ying, C., Liu, L, Workman, U.R., and Berger, S.L (1998). Repression of GCN5 histone acetyltransferase activity via bromodomain-mediated binding and phosphorylation by the Ku-DNA-dependent protein kinase complex. Mol. Cell. Biol. 18, 1349-1358.
3. Blanco, J.C., Minucci, S., Lu, J., Yang, X.J., Walker, K.K., Chen, H., Evans, R.M., Nakatani, Y., and Ozato, K. (1998). The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev. 12, 1638-1651.
4. Brownell, U.E., Zhou, J., Ranalli, T., Kobayashi, R., Edmondson, D.G., Roth, S.Y., and Allis, C.D. (1996). Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell 84, 843-851.
5. Chakravarti, D., LaMorte, V.J., Nelson, M.C., Nakajima, T., Schulman, I.G., Jujuilon, J., Montminy, M., and Evans, R.M. (1996). Role of CBP/ p300 in nuclear receptor signaling. Nature 383, 99-103.
6. Chen, H., Lin, R.J., Schlitz, R.L, Chakravarti, D., Nash, A., Nagy, L, Privalsky, M.L, Nakatani, Y., and Evans, R.M. (1997). Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP p300. Cell 90, 569-580.
7. Dyson, N., and Harlow, E. (1992). Adenovirus E1 Atargets key regulators of cell proliferation. Cancer surveys. In Tumor Suppressor Genes: The Cell Cycle and Cancer, A. Levine, ed. (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press). 12, 161-195.
8. Eckner, R., Ewen, M.E., Newsome, D., Gerdes, M., DeCaprio, U.A., Lawrence, J.B., and Livingston, D.M. (1994). Molecular cloning and functional analysis of the adenovirus E1 A-associated 300- kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8, 869-884.
9. Glass, C.K., Rose, D.W., and Rosenfeld, M.G. (1997). Nuclear receptor coactivators. Curr. Opin. Cell Biol. 9, 222-232.
10. Grant, P.A., Schieltz, D., Pray-Grant, M.G., Steger, D.J., Reese, J.C., Yates, J.R., III, and Workman, J.L (1998). A subset of TAF(II)s are integral components of the SAGA complex required for nucleosome acetylation and transcriptional stimulation. Cell 94, 45-53.
11. Grunstein, M. (1997). Histone acetylation in chromatin structure and transcription. Nature 389, 349-352.
12. Gu, W., and Roeder, R.G. (1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606.
13. Gu, W., Shi, X.L., and Roeder, R.G. (1997). Synergistic activation of transcription by CBP and p53. Nature 387, 819-823.
14. Imhof, A., Yang, X.-J., Ogryzko, V., Nakatani, Y., Wolffe, A.P., and Ge, H. (1997). Acetylation of general transcription factors by histone acetyltransferases. Curr. Biol. 7, 689-692.
15. Janknecht, R., and Hunter, T. (1996). A growing coactivator network. Nature 383, 22-23.
16. Kamei, Y., Xu, L, Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R.A., Rose, D.W., Glass, C.K., and Rosenfeld, M.G. (1996). ACBP integrator complex mediates transcrlptlonal activation and AP-1 Inhibition by nuclear receptors. Cell 85, 403-414.
17. Klmelman, D., Miller, U.S., Porter, D., and Roberts, B.E. (1985). E1A regions of the human adenovlruses and the highly oncogenlc simian adenovlrus 7 are closely related. J. Vlrol. 53, 399-409.
18. Korzus, E., Torchia, J., Rose, D.W., Xu, L, Kurokawa, R., Mclnerney, E.M., Mullen, T.-M., Glass, C.K., and Rosenfeld, M.G. (1998). Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279, 703-707.
19. Kuo, M.-H., Zhou, J., Jambeck, P., Churchill, M.E.A., and Allis, D.C. (1998). Histone acetyltransferase activity of yeast Gcn5 is required for the activation of target genes in vivo. Genes Dev. 12, 627-639.
20. Kurokawa, R., Kalafus, D., Ogliastro, M.-H., Kioussi, C., Xu, L., Torchia, J., Rosenfeld, M.G., and Glass, C.K. (1998). Differential use of CREB binding protein-coactivator complexes. Science 279, 700-703.
21. Lill, N., Grossman, S.R., Ginsberg, D., DeCaprio, J., and Livingston, D.M. (1997). Binding and modulation of p53 by p300 CBP coactivators. Nature 387, 823-827.
22. Luger, K., Mader, A.W., Richmond, R.K., Sargent, D.F., and Richmond, T.J. (1997). Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 389, 251-260.
23. Mizzen, C.A., and Allis, C.D. (1998). Linking histone acetylation to transcriptional regulation. Cell Mol. Life Sci. 54, 6-20.
24. Mizzen, C., Yang, X., Kokubo, T., Brownell, J., Bannister, A., OwenHughes, T., Workman, J., Wang, L, Berger, S., Kouzarides, T., Nakatani, Y., and Allis, C.D. (1996). The TAFII250 subunit of TFIID has histone acetyltransferase activity. Cell 87, 1261-1270.
25. Moran, E. (1993). DNA tumor virus transforming proteins and the cell cycle. Curr. Opin. Genet. Dev. 3, 63-70.
26. Naar, A.M., Beaurang, P.A., Robinson, K.M., Oliner, J.D., Avizonis, D., Scheek, S., Zwicker, J., Kadonaga, J.T., and Tjian, R. (1998). Chromatin, TAFs, and a novel multiprotein coactivator are required for synergistic activation by Sp1 andSREBP-1a in vitro. Genes Dev. 12, 3020-31.
27. Nakajima, T., Uchida, C., Anderson, S.F., Lee, C.-G., Hurwitz, J., Parvin, J.D., and Montminy, M. (1997a). RNA helicase A mediates association of CBP with RNA polymerase II. Cell 90, 1107-1112.
28. Nakajima, T., Uchida, C., Anderson, S.F., Parvin, J.D., and Montminy, M. (1997b). Analysis of a cAMP-responsive activator reveals a two component mechanism for transcriptional induction via signal dependent factors. Genes Dev. 11, 738-743.
29. Ogryzko, V.V., Schiltz, R.L., Russanova, V., Howard, B.H., and Nakatani, Y. (1996). The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87, 953-959.
30. Ogryzko, V.V., Kotani, T., Zhang, X., Schiltz, R.L., Howard, T., Yang, X.-J., Howard, B.H., Qin, J., and Nakatani, Y. (1998). Histone-like TAFs within the PCAF histone acetylase complex. Cell 94, 35-44.
31. O'Neil, T.E., Roberge, M., and Bradbury, E.M. (1992). Nucleosome arrays inhibit both initiation and elongation of transcripts by bacteriophage T7 RNA polymerase. J. Mol. Biol. 223, 67-87.
32. Purl, P.L, Sartorelli, V., Yang, X.-J., Hamamori, Y., Ogryzko, V.V., Howard, B.H., Graessman, A., Nakatani, Y., and Levrero, M. (1997). Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol. Cell 1, 35-45.
33. Rundlett, S.E., Carmen, A.A., Suka, N., Turner, B.M., and Grunstein, M. (1998). Transcriptional repression by UME6 involves deacetylation of lysine 5 of histone H4 by RPD3. Nature 392, 831-835.
34. Serrano, M., Hannon, G.J., and Beach, D. (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704-707.
35. Sherr, C.J., and Roberts, J.M. (1995). Inhibitors of mammalian G1 cyclin dependent kinases. Genes Dev. 9, 1149-1163.
36. Smith, C.L., Onate, S.A., Tsai, M.-J., and O'Malley, B.W. (1996). CREB binding protein acts synergistically with steroid receptor coactivator 1 to enhance steroid receptor-dependent transcription. Proc. Natl. Acad. Sci. USA 93, 8884-8888.
37. Spencer, T., Jenster, G., Burcin, M., Allis, C.D., Zhou, J., Mizzen, G., McKenna, N., Onate, S., Tsai, S., Tsai, M., and O'Malley, B. (1997). Steroid receptor coactivator-1 is a historie acetyltransferase. Nature 389, 194-198.
38. Struhl, K. (1998). Historie acetylation and transcriptional regulatory mechanisms. Genes Dev. 12, 599-606.
39. Utley, R.T., Ikeda, K., Grant, P.A., Cote, J., Steger, D.J., Eberharter, A., John, S., and Workman, J.L. (1998). Transcriptional activators direct historie acetyltransferase complexes to nucleosomes. Nature 394, 498-502.
40. Wang, H.G., Rikitake, Y., Carter, M.C., Yaciuk, P., Abraham, S.E., Zerler, B., and Moran, E. (1993). Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J. Virol. 67, 476-488.
41. Wang, L, Liu, L., and Berger, S.L. (1998). Critical residues for historie acetylation by Gcn5, functioning in Ada and SAGA complexes, are also required for transcriptional function in vivo. Genes Dev. 12, 640-653.
42. Yang, X.-J., Ogryzko, V.V., Nishikawa, J., Howard, B.H., and Naka-tani, Y. (1996). A p300 CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382, 319-324.
43. Yao, T.-P., Ku, G., Zhou, N., Scully, R., and Livingston, D.M. (1996). The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc. Natl. Acad. Sci. USA 93, 10626-10631.
44. Zhang, J.J., Vinkemeier, U., Gu, W., Chakravarti, D., Horvath, C.M., and Darnell, J.E.J. (1996). Two contact regions between Stall and CBP p300 in Interferon γ signaling. Proc. Natl. Acad. Sci. USA 93, 15092-15096.